Containing hydralazine or its salts
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: > Other: > Other > Other: > Cardiovascular medicaments: > Containing hydralazine or its salts
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3004.90.92.20
Hydralazine Hydrochloride 25mg Tablets
These are oral tablets containing 25mg of hydralazine hydrochloride, a vasodilator used to treat hypertension and heart failure. Classified under HTS 3004.90.92.20 as a cardiovascular medicament put up in measured doses for retail sale, consisting of unmixed active ingredient in tablet form.
Apresoline 25mg Scored Tablets (Hydralazine Brand)
Brand-name Apresoline tablets with 25mg hydralazine hydrochloride, scored for dose adjustment in hypertensive emergencies. Put up in retail packs, classified in HTS 3004.90.92.20 for specific hydralazine cardiovascular medicaments.
Generic Hydralazine 50mg Film-Coated Tablets
Film-coated generic tablets delivering 50mg hydralazine with improved swallowability for daily antihypertensive regimens. HTS 3004.90.92.20 covers this as dosage-form cardiovascular product containing hydralazine salts.
Pediatric Hydralazine 1mg/ml Suspension
Compounded oral suspension at 1mg/ml hydralazine for pediatric hypertensive patients, shaken before use. Put up in measured dose bottles for retail pharmacy, under HTS 3004.90.92.20 as therapeutic cardiovascular mixed product.
Hydralazine 20mg Transdermal Patch
24-hour transdermal patch system delivering 20mg hydralazine daily for compliant hypertension management. Specifically included in HTS 3004.90.92.20 description for transdermal administration systems of cardiovascular medicaments.
Hydralazine 40mg Chewable Tablets
Chewable tablets with 40mg hydralazine, flavored for elderly patients with dysphagia in hypertension control. Dosage form for retail sale qualifies under HTS 3004.90.92.20 as measured cardiovascular medicament.
Hydralazine 50mg Extended-Release Tablets
Extended-release tablets providing 50mg hydralazine for once-daily dosing in managing chronic hypertension. Falls under HTS 3004.90.92.20 as a mixed product in measured doses for therapeutic cardiovascular use, put up for retail sale.
Hydralazine 10mg/5ml Oral Solution
Liquid oral solution with 10mg hydralazine per 5ml dose, formulated for patients requiring flexible dosing in heart failure therapy. HTS 3004.90.92.20 applies as a cardiovascular medicament in measured doses for retail, unmixed per chapter notes.
Hydralazine 100mg Injection Vials
Sterile injectable vials containing 100mg hydralazine for IV use in severe hypertension crises. Meets HTS 3004.90.92.20 as unmixed cardiovascular product in measured doses, suitable for hospital retail dispensing.
Hydralazine-Isosorbide Fixed Combination 37.5/20mg Tablets
Combination tablets with hydralazine 37.5mg and isosorbide dinitrate 20mg for heart failure in African-American patients (BiDil). Classified under HTS 3004.90.92.20 due to primary hydralazine content as specified cardiovascular medicament.